Please login to the form below

Not currently logged in
Email:
Password:

medicines use

This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.

Business warning as talk of Brexit ‘No deal’ grows

Business warning as talk of Brexit ‘No deal’ grows

Asked for its views, a spokesperson for the UK pharma industry association the ABPI said it reiterated its message from 7 December, when the health secretary Matt Hancock issued medicines-specific ... and the need for a significant increase in the use of

Latest news

More from news
Approximately 0 fully matching, plus 244 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest appointments

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. . ... and innovative medicines.”.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions

  • EAHP elects Joan Peppard as president EAHP elects Joan Peppard as president

    As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.

  • Marschall Runge joins Lilly’s board of directors Marschall Runge joins Lilly’s board of directors

    Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare ... His appreciation of the importance of scientific research,

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • NHS medicines optimisation milestone

    by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS

  • Patient Engagement and Experience Conference, 16-17 May

    The conference brings together HCPs, patients, payers, government, pharma and industry under one roof to focus on patients’ engagement and experience of their treatment to improve the real-world use of ... medicines.Speaking at the conference .

  • "Legal highs" ruling leaves illegal labs laughing

    There is a huge amount of off-label use of licensed medicines by medically qualified prescribers. ... There are also many agents that have crossed the line from illegal to legal use, such as cannabinoids for MS, as well as previously approved medicines

  • Making good practice common practice in rare disease

    Good listeners use a number of techniques - here are two simple examples you can try yourself:. ... Researchers found that the size of the drawing predicted speed of return to work, cardiac anxiety, use of alternative medicines and number of phone calls

  • Brexit and Pharma: A match made in hell.

    At the start of my career, the Irish Medicines Board (now the HPRA) licenced new products. ... Over the past 22 years, the EMA has been responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics